Medicare Enrolled

Dr. Henry Prost, M.D.

Endocrinology · Colleyville, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
7141 COLLEYVILLE BLVD, Colleyville, TX 76034
8177933422
Registered in NPPES since 2006
NPI: 1841229812 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Prost from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Prost? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Prost

Dr. Henry Prost is an endocrinology specialist in Colleyville, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Prost performed 2,009 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Prost received a total of $22,952 from 69 pharmaceutical and/or device companies across 1017 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Prost is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 21% volume in TX $22,952 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
2,009
Medicare services
Top 21% in TX for endocrinology
Not available
Unique patients (not deduplicated)
$56
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
749 $87 $235
Blood glucose test using hand-held instrument
A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels.
395 $3 $19
Ultrasound of head and neck soft tissue
This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation.
355 $75 $270
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
184 $58 $158
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
134 $10 $66
Lipid panel (cholesterol and triglycerides)
A blood test that measures cholesterol and triglyceride levels.
127 $13 $77
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
43 $121 $358
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
22 $27 $100
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$22,952
Total received (2018-2024)
Avg $3,279/year across 7 years
Top 20% in TX for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
69
Companies
1,017
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,131
2023
$2,598
2022
$2,341
2021
$2,735
2020
$2,280
2019
$4,341
2018
$6,526

Payments by company (2024)

Lilly USA, LLC
$403
Abbott Laboratories
$212
Novo Nordisk Inc
$186
Amgen Inc.
$163
Insulet Corporation
$142
IBSA Pharma Inc.
$111
ABBVIE INC.
$105
Xeris Pharmaceuticals, Inc.
$103
BETA BIONICS, INC.
$75
Amneal Pharmaceuticals LLC
$69
Acella Pharmaceuticals, LLC
$59
Medtronic, Inc.
$56
Antares Pharma, Inc.
$55
Tandem Diabetes Care, Inc.
$50
Corcept Therapeutics
$37
Neurocrine Biosciences, Inc.
$34
RECORDATI_RARE_DISEASES_INC.
$31
Nevro Corp.
$31
SANOFI-AVENTIS U.S. LLC
$30
Astellas Pharma US Inc
$29
Boehringer Ingelheim Pharmaceuticals, Inc.
$27
Chiesi USA, Inc.
$25
Dexcom, Inc.
$19
Alexion Pharmaceuticals, Inc.
$17
VIVUS LLC
$16
Bayer Healthcare Pharmaceuticals Inc.
$16
CeQur Corporation
$15
Avvisto Therapeutics, LLC
$15
Top 3 companies account for 37.6% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie, Inc.
$6,030
Lilly USA, LLC
$2,132
AstraZeneca Pharmaceuticals LP
$1,924
Novo Nordisk Inc
$1,684
SANOFI-AVENTIS U.S. LLC
$1,007
Abbott Laboratories
$960
Amarin Pharma Inc.
$777
Boehringer Ingelheim Pharmaceuticals, Inc.
$626
Amgen Inc.
$542
Mannkind Corporation
$413
Dexcom, Inc.
$407
IBSA Pharma Inc.
$396
AbbVie Inc.
$389
Insulet Corporation
$373
RECORDATI_RARE_DISEASES_INC.
$359
Antares Pharma, Inc.
$341
Merck Sharp & Dohme Corporation
$325
ABBVIE INC.
$322
MannKind Corporation
$303
Kowa Pharmaceuticals America, Inc.
$270
Amneal Pharmaceuticals LLC
$238
Janssen Pharmaceuticals, Inc
$191
Alexion Pharmaceuticals, Inc.
$170
Corcept Therapeutics
$153
Medtronic, Inc.
$147
LifeScan, Inc.
$128
Bayer Healthcare Pharmaceuticals Inc.
$128
CeQur Corporation
$123
Xeris Pharmaceuticals, Inc.
$123
Becton, Dickinson and Company
$121
Shire North American Group Inc
$117
Acella Pharmaceuticals, LLC
$108
Radius Health, Inc.
$96
Tandem Diabetes Care, Inc.
$91
Ultragenyx Pharmaceutical Inc.
$88
Medtronic MiniMed, Inc.
$78
Nevro Corp.
$77
BETA BIONICS, INC.
$75
DEXCOM, INC.
$73
Horizon Therapeutics plc
$70
Currax Pharmaceuticals LLC
$63
Tolmar, Inc.
$59
VistaPharm, Inc.
$55
PFIZER INC.
$52
Intuity Medical Inc
$51
Merck Sharp & Dohme LLC
$48
Zealand Pharma US, Inc.
$47
VIVUS LLC
$47
Supernus Pharmaceuticals, Inc.
$43
Bayer HealthCare Pharmaceuticals Inc.
$42
Takeda Pharmaceuticals U.S.A., Inc.
$40
Alvogen Inc
$40
Clarus Therapeutics Inc.
$37
Neurocrine Biosciences, Inc.
$34
EUSA Pharma (US) LLC
$34
Eisai Inc.
$34
Astellas Pharma US Inc
$29
Companion Medical, Inc.
$29
Acerus Pharmaceuticals Corporation
$26
Chiesi USA, Inc.
$25
Novartis Pharmaceuticals Corporation
$20
Ascendis Pharma Inc
$19
Amryt Pharma Holdings Ltd
$17
Amphastar Pharmaceuticals, Inc.
$17
Alfasigma USA, Inc.
$16
EISAI INC.
$16
Avvisto Therapeutics, LLC
$15
ARBOR PHARMACEUTICALS, INC.
$11
Roche Diabetes Care, Inc.
$11
Top 3 companies account for 43.9% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · Belviq · CONTRAVE · CYCLOSET · CeQur Simplicity · Crysvita · DC ACCU-CHEK Education Materials · DEXCOM CGM · DEXCOM G6 TRANSMITTER · DEXCOM G7 GSS (161) · DIABETES - DISEASE · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · Edarbi · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · HUMALOG · HUMULIN · HUMULIN U · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · ISTURISA · InPen · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LEQVIO · LICART · LYUMJEV · Licart · Livalo · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 670G System · Minimed 770G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NOCDURNA · NP Thyroid 60 · Natesto · OT Verio Flex Starter Kit · OTREXUP · Omnipod · OneTouch · OneTouch Verio Reflect · Ozempic · PRALUENT · PREVNAR 20 · Pogo Automatic Blood Glucose Monitoring System · Prolia · QSYMIA · RECORLEV · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STEGLATRO · STEGLUJAN · STRENSIQ · SYNTHROID · Saxenda · Senza · Sylvant · Synthroid · TEPEZZA · TERIPARATIDE · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Thyquidity · Tirosint · Tresiba · Tymlos · UNITHROID · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XYOSTED · ZEGALOGUE · ZEPBOUND · iLet Bionic Pancreas · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an endocrinology specialist in Colleyville?
Compare endocrinologists in the Colleyville area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists in nearby ZIP areas
108
County median income
$81,905
Nearest hospital to ZIP centroid (approximate)
SAINT CAMILLUS MEDICAL CENTER
2.9 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Prost is a clinical cardiology specialist, with above-average Medicare volume (top 21% in TX), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Prost experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Prost performed 749 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Prost receive payments from pharmaceutical companies?
Yes. Dr. Prost received a total of $22,952 from 69 companies across 1,017 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Prost's costs compare to other endocrinologists in Colleyville?
Dr. Prost's average Medicare payment per service is $56. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Prost) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →